Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder

Sarah Kayser, Bettina Bewernick, Nikolai Axmacher, Thomas E. Schlaepfer

Research output: Contribution to journalArticle

Abstract

Electroconvulsive therapy (ECT) is a highly efficacious treatment for severe depression. However, a disadvantage of ECT is the risk of cognitive side effects. Magnetic seizure therapy (MST) is a novel treatment modality, by which therapeutic seizures are induced using rapidly alternating strong magnetic fields. In this case study, we report on successful MST treatment of an episode of otherwise treatment-resistant depression in a patient with bipolar I disorder. Compared with published ECT results, MST seizures in this case report were of shorter duration, lower ictal electroencephalogram amplitude, and less pronounced postictal suppression. Furthermore, the patient did not experience subjective side effects and particularly recovered time to full orientation more quickly with MST than what has been previously described for ECT. Taken together, these results suggest that MST, compared with ECT, might have antidepressant effects and may have fewer clinical side effects.

Original languageEnglish (US)
Pages (from-to)137-140
Number of pages4
JournalJournal of ECT
Volume25
Issue number2
DOIs
StatePublished - Jun 1 2009

Keywords

  • Cognitive side effects
  • Depression
  • EEG
  • Electroconvulsive therapy (ECT)
  • Magnetic seizure therapy (MST)

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder'. Together they form a unique fingerprint.

  • Cite this